108 related articles for article (PubMed ID: 21679092)
1. Autoimmune phenomena in untreated and treated marginal zone lymphoma.
Grabska J; Dasanu CA
Expert Opin Pharmacother; 2011 Oct; 12(15):2369-79. PubMed ID: 21679092
[TBL] [Abstract][Full Text] [Related]
2. Immune alterations in untreated and treated myelodysplastic syndrome.
Mewawalla P; Dasanu CA
Expert Opin Drug Saf; 2011 May; 10(3):351-61. PubMed ID: 21417834
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Pattern of Autoimmune Conditions in Patients with Marginal Zone Lymphoma: A Single Institution Experience.
Dasanu CA; Bockorny B; Grabska J; Codreanu I
Conn Med; 2015 Apr; 79(4):197-200. PubMed ID: 26259295
[TBL] [Abstract][Full Text] [Related]
4. Mucosa-associated lymphoid tissue (MALT) lymphoma presenting as subglottic stenosis: single-agent treatment using rituximab.
Bielinski C; Luu HS; Mau T
Otolaryngol Head Neck Surg; 2014 Feb; 150(2):334-5. PubMed ID: 24334958
[No Abstract] [Full Text] [Related]
5. Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab.
Ates O; Sunar V; Babacan T; Akin S; Kertmen N; Altundag K
J BUON; 2015; 20(1):349. PubMed ID: 25778339
[No Abstract] [Full Text] [Related]
6. Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study.
Kang HJ; Kim WS; Kim SJ; Lee JJ; Yang DH; Kim JS; Lee SR; Lee GW; Kim HJ; Kim HY; Oh SY; Kim HC; Eom HS; Chung J; Park J; Suh C; Ryoo BY
Ann Hematol; 2012 Apr; 91(4):543-51. PubMed ID: 21922208
[TBL] [Abstract][Full Text] [Related]
7. Syndrome of inappropriate antidiuretic hormone secretion due to marginal zone lymphoma: responding to rituximab.
Bockorny B; Dasanu CA
Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):220-2. PubMed ID: 22578816
[No Abstract] [Full Text] [Related]
8. Remission of acquired von Willebrand syndrome after successful treatment of gastric MALT lymphoma.
Biondo F; Matturro A; Santoro C; Leporace A; D'Elia G; Baldacci E; Pignoloni P; Pulsoni A; Foà R; Mazzucconi M
Haemophilia; 2012 Jan; 18(1):e34-5. PubMed ID: 22059776
[No Abstract] [Full Text] [Related]
9. Primary cutaneous marginal zone B-cell lymphoma: An atypical case.
Velázquez D; de Pablo P; García D; Ramírez JR
Dermatol Online J; 2010 Dec; 16(12):5. PubMed ID: 21199631
[TBL] [Abstract][Full Text] [Related]
10. Primary spinal marginal zone lymphoma: case report and review of the literature.
Ahmadi SA; Frank S; Hänggi D; Eicker SO
Neurosurgery; 2012 Aug; 71(2):E495-508; discussion E508. PubMed ID: 22314752
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of IgG4-related disease following treatment with rituximab.
Murakami J; Matsui S; Ishizawa S; Arita K; Wada A; Miyazono T; Hounoki H; Shinoda K; Taki H; Sugiyama T
Mod Rheumatol; 2013 Nov; 23(6):1226-30. PubMed ID: 22956241
[TBL] [Abstract][Full Text] [Related]
12. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
[TBL] [Abstract][Full Text] [Related]
13. One biopsy, two diagnoses: statin-induced autoimmune myopathy in combination with extranodal marginal zone lymphoma.
Michiels S; Dierickx D; Taelman V; Tousseyn T; Lenaerts J; De Langhe E
Clin Exp Rheumatol; 2017; 35(4):717. PubMed ID: 28516888
[No Abstract] [Full Text] [Related]
14. Marginal Zone Lymphoma: State-of-the-Art Treatment.
Sindel A; Al-Juhaishi T; Yazbeck V
Curr Treat Options Oncol; 2019 Dec; 20(12):90. PubMed ID: 31807935
[TBL] [Abstract][Full Text] [Related]
15. Intralesional rituximab for primary iris lymphoma.
Demirci H; Grant JS; Elner VM
JAMA Ophthalmol; 2015 Jan; 133(1):104-5. PubMed ID: 25211092
[No Abstract] [Full Text] [Related]
16. Acquired angioedema and marginal zone lymphoma.
Lam DH; Levy NB; Nickerson JM; Gruenberg DA; Lansigan F
J Clin Oncol; 2012 Jun; 30(16):e151-3. PubMed ID: 22508826
[No Abstract] [Full Text] [Related]
17. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
[TBL] [Abstract][Full Text] [Related]
18. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T cell-mediated gastritis after rituximab treatment for gastric malt lymphoma.
Stalika E; Kanellis G; Papalexandri A; Iskas M; Vrakidou E; Demonakou M; Anagnostopoulos A; Stamatopoulos K; Papadaki T
Leuk Lymphoma; 2014 Mar; 55(3):702-5. PubMed ID: 23725385
[No Abstract] [Full Text] [Related]
20. Marginal zone B-cell lymphomas.
Sagaert X; Tousseyn T
Discov Med; 2010 Jul; 10(50):79-86. PubMed ID: 20670602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
